Zhejiang Shapuaisi’s patent for single-dose bendazac lysine eye drop packaging declared void
Summary: Zhejiang Shapuaisi has been told that its patent for single-dose bendazac lysine eye drop packaging is void, following questions over the effectiveness of bendazac lysine eye drops in Dec. 2017.Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (Zh...
Amino Acids China E-News 201801